Aster Healthcare Share Price History and Returns 2018 to 2024
Aster DM Healthcare Limited | |||
 | Price: ₹486.35 | ||
| 52 Week Low: ₹311.10 52 Week High: ₹558.00 | |||
| Market Capital: 21,566.79 Crore (Largecap) | |||
| Healthcare -> Medical Care Facilities | |||
Show Table of Contents
Table of Contents
- 1: Aster Healthcare Stock Highlights
- 1.1: 52-Week High Low
- 1.2: All Time High
- 2: Aster Healthcare Recent Performance
- 3: Aster Healthcare Stock Price Chart From 2018 to 2024
- 4: Aster Healthcare Stock Price History Table From 2018 to 2024
- 5: Analyzing the Impact of Investing in Aster Healthcare
- 5.1: Aster Healthcare Stock Returns In Last 5 Years
- 6: Aster Healthcare Returns vs Bank FD Returns
Aster Healthcare Stock Highlights
As of 20 Dec 2024, Aster Healthcare Stock price is ₹486.35 which is ₹71.65 below 52-week high of ₹558.00 and ₹175.25 above 52-week low of ₹311.10
52-Week High Low
- Aster Healthcare 52-Week High is ₹558.00 occurred on 15 Apr 2024
- Aster Healthcare 52-Week Low is ₹311.10 occurred on 04 Jun 2024
All Time High
- The all-time high or the highest price that Aster Healthcare stocks have ever touched was ₹558.00 and this occurred on 15 Apr 2024.
- The highest closing price at which Aster Healthcare stocks have ever closed was ₹522.75 recorded on 15 Apr 2024.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Aster Healthcare Recent Performance
Over the past 15 trading days, the value of Aster Healthcare's stock has decreased by ₹7.65 (-1.55%). On 28 Nov 2024, its one share was worth ₹494 and by 20 Dec 2024, the value dropped to ₹486.35. During this period it created a highest high of ₹507.50 and lowest low of ₹472.30.
Click on legend items to show/hide respective price lines
Aster Healthcare Stock Price Chart From 2018 to 2024
Click on legend items to show/hide respective price lines
Aster Healthcare Stock Price History Table From 2018 to 2024
| Year | Aster Healthcare | YOY Chg% | ↑High - ↓Low |
|---|---|---|---|
| 2024 | ₹485.55 | 18.4% | ↑ ₹524.00 ↓ ₹472.00 |
| 2023 | ₹409.80 | 77.3% | ↑ ₹424.00 ↓ ₹201.00 |
| 2022 | ₹231.10 | 32.9% | ↑ ₹275.00 ↓ ₹158.00 |
| 2021 | ₹173.80 | 4.7% | ↑ ₹237.00 ↓ ₹132.00 |
| 2020 | ₹165.85 | 3.1% | ↑ ₹181.00 ↓ ₹78.00 |
| 2019 | ₹160.75 | 3.5% | ↑ ₹168.00 ↓ ₹109.00 |
| 2018 | ₹155.30 | - | ↑ ₹188.00 ↓ ₹140.00 |
Analyzing the Impact of Investing in Aster Healthcare
Aster Healthcare Stock price in the year 2018 was ₹155.30. If you had invested ₹10,000 in Aster Healthcare Stock in 2018, in 6 years, your investment would have grown to ₹31,265 by the end of 2024. This represents a positive return of 212% from 2018 to 2024, with a compound annual growth rate (CAGR) of 20.9%.
Aster Healthcare Stock Returns In Last 5 Years
- Its highest stock price in the last 5 years was: ₹524.65 and lowest was: ₹78.00
- Aster Healthcare Stock price in 2019 was ₹160.75
- By 2024, its stock price rose to ₹485.55
- It gave a positive return of over 202.1% with a CAGR of 24.7% over the last 5 years
- If you had invested ₹10,000 in Aster Healthcare in 2019 then in 5 years, your investment would have grown to ₹30,205.28 by 2024, which is 3.02 times of your initial investment.
Aster Healthcare Returns vs Bank FD Returns
| Investment Type | Initial Amount | Final Value | Total Returns |
|---|---|---|---|
| Aster Healthcare Shares | ₹10,000 | ₹31,265.29 | 212.7% |
| Bank FD (Simple Interest) | ₹10,000 | ₹13,600 | 36.0% |
| Bank FD (Compound Interest) | ₹10,000 | ₹14,185.19 | 41.9% |
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
